EPHA2 and neoplasm: Although both studies demonstrate that tumor cell-specific EphA2 has a detrimental impact on T-cell-mediated immunity, one suggests that granulocytic myeloid cells play an intermediary role, while the other suggests monocytic myeloid cells.